Oppenheimer cuts Liquidia stock rating on launch concerns - Investing.com
Yesterday • Google News
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPI.
Yesterday • Google News
22 hours ago • Google News